jz体育

<address id="1b7bb"><listing id="1b7bb"><mark id="1b7bb"></mark></listing></address>

<sub id="1b7bb"><dfn id="1b7bb"><ins id="1b7bb"></ins></dfn></sub>

<sub id="1b7bb"><var id="1b7bb"><ins id="1b7bb"></ins></var></sub>

    <address id="1b7bb"><ruby id="1b7bb"><sub id="1b7bb"></sub></ruby></address>
    <sub id="1b7bb"><dfn id="1b7bb"><mark id="1b7bb"></mark></dfn></sub>

      <sub id="1b7bb"><var id="1b7bb"><ins id="1b7bb"></ins></var></sub>
      <address id="1b7bb"><dfn id="1b7bb"><mark id="1b7bb"></mark></dfn></address>

        <address id="1b7bb"></address>

      <sub id="1b7bb"><dfn id="1b7bb"><mark id="1b7bb"></mark></dfn></sub>
      <sub id="1b7bb"><dfn id="1b7bb"></dfn></sub>

      <thead id="1b7bb"><var id="1b7bb"><output id="1b7bb"></output></var></thead>
      <address id="1b7bb"><listing id="1b7bb"></listing></address>

      <sub id="1b7bb"><listing id="1b7bb"></listing></sub>

      Home / Research / Academics / Content
      Academics
      Breakthrough of Chen Mingzhou’s team in HPIV replication published in Cell Reports
      Author:  Date:2019-12-14  Clicks:

      On November 19th, Cell Reports, the sub-journal of Cell, published the latest research findings of Professor Chen Mingzhou’s team on replication of the human parainfluenza virus. Prof. Chen works in the State Key Laboratory of Virology in the College of Life Sciences. His work has provided a theoretical basis for the design of a new antiviral drug that directly targets negative-strand RNA virus replication platforms.

      The paper is entitled PI4KB on inclusion bodies formed by ER membrane remodeling facilitates replication of human parainfluenza virus type 3. Li Zhifei, a doctoral student from the College of Life Sciences, is the first author. Professor Chen Mingzhou and Associate Professor Qin Yali are co-corresponding authors.

      The research is jointly funded by the National Natural Science Foundation of China, the National Key Research and Development Project, the National Science and Technology Major Project and the Science Fund for Creative Groups of Hubei Province.

      The Human Parainfluenza Virus (HPIV) is a typical negative-strand RNA virus. It is the major cause of respiratory tract infection among infants, young children and immunocompromised groups. HPIV can cause bronchitis, pneumonia and asthma. However, there is currently no vaccine or antiviral drug that can effectively prevent and treat human parainfluenza virus infection.

      Chen’s team have been engaged in the research of the transcription, replication and related molecular biology of unsegmented negative-strand RNA virus for a long time. Previous studies have shown that HPIV3 infection can form inclusion bodies, which are the center of virus replication and RNA synthesis in cells (Zhang et al., 2013; 2017. Journal of Virology). Inclusion bodies also play a role in regulating the antiviral response of host cells. It can conceal the synthesized RNA, thus inhibiting the formation of stress granules (SGs) caused by viral infection and promoting the reproduction of HPIV (Hu et ., 2018. Plos Pathogens).

      On the basis of previous work, Chen's team published an article in Cell Reports, revealing that negative-strand RNA viruses use the endomembrane system to form replication sites and gather PI4K kinases to create a membrane lipid environment rich in PI4P, which promotes the replication of HPIV. HPIV fragments the endoplasmic reticulum (ER) and uses the ER components to form inclusion bodies. Fragmented ER prevents inclusion bodies from being hydrolyzed and thus ensures the effective replication of viruses. In addition, the P protein in the virus recruits PI4KB to form a membrane lipid environment rich in PI4P, which effectively promotes viral replication. Finally, Chen’s team analyzed the relationship between PI4K and other negative-strand RNA viruses’ inclusion bodies, and found that HRSV utilizess the nucleoprotein to recruit PI4K to form PI4P in inclusion bodies, which also contain endoplasmic reticulum components.

      Link to the paper: https://www.cell.com/cell-reports/fulltext/S2211-1247(19)31366-X

      Rewritten by: Liu Tongxv, edited by Cao Siyi, Shen Yuxi, Shi Weiya and Hu Sijia

      Source:

      Prev Section:Latest updates on the battle against 2019-NCP: JAMA published the latest research results of Peng Zhiyong team from Zhongnan Hospital of WHU
      Next Section:Nucleic Acids Research publishes breakthrough in functional genomics of Malvaceae plants by Zhou Yu and Zhu Yuxian’s group

      [ Close ]

      Copyright @ 2014 Wuhan University | by sigutech

      Web Traffic:
      <address id="1b7bb"><listing id="1b7bb"><mark id="1b7bb"></mark></listing></address>

      <sub id="1b7bb"><dfn id="1b7bb"><ins id="1b7bb"></ins></dfn></sub>

      <sub id="1b7bb"><var id="1b7bb"><ins id="1b7bb"></ins></var></sub>

        <address id="1b7bb"><ruby id="1b7bb"><sub id="1b7bb"></sub></ruby></address>
        <sub id="1b7bb"><dfn id="1b7bb"><mark id="1b7bb"></mark></dfn></sub>

          <sub id="1b7bb"><var id="1b7bb"><ins id="1b7bb"></ins></var></sub>
          <address id="1b7bb"><dfn id="1b7bb"><mark id="1b7bb"></mark></dfn></address>

            <address id="1b7bb"></address>

          <sub id="1b7bb"><dfn id="1b7bb"><mark id="1b7bb"></mark></dfn></sub>
          <sub id="1b7bb"><dfn id="1b7bb"></dfn></sub>

          <thead id="1b7bb"><var id="1b7bb"><output id="1b7bb"></output></var></thead>
          <address id="1b7bb"><listing id="1b7bb"></listing></address>

          <sub id="1b7bb"><listing id="1b7bb"></listing></sub>

          体彩官网首页下载

          澳门银河娱乐场网站

          至富线上平台

          皇冠现金足球投注网

          电竞投注平台

          vip亚搏

          金牛网首页

          www.c9.com官网

          澳门银河官网官方网站